Loading…

Humoral immune response to cruzipain and cardiac dysfunction in chronic Chagas disease

The humoral immune response to epitopes expressed on cruzipain was evaluated in 31 Chagas disease patients (CDP) with different degrees of cardiac dysfunction. We took advantage of the availability of anti- Trypanosoma cruzi microsomal fraction monoclonal antibodies (MoAbs) reactive with epitopes th...

Full description

Saved in:
Bibliographic Details
Published in:Immunology letters 2001-10, Vol.78 (3), p.135-142
Main Authors: Duschak, Vilma G, Riarte, Adelina, Segura, Elsa L, Laucella, Susana A
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c444t-de75b04b6dd9529cc6873343489275767850803fc67069d27e3ddc90f0067ee63
cites cdi_FETCH-LOGICAL-c444t-de75b04b6dd9529cc6873343489275767850803fc67069d27e3ddc90f0067ee63
container_end_page 142
container_issue 3
container_start_page 135
container_title Immunology letters
container_volume 78
creator Duschak, Vilma G
Riarte, Adelina
Segura, Elsa L
Laucella, Susana A
description The humoral immune response to epitopes expressed on cruzipain was evaluated in 31 Chagas disease patients (CDP) with different degrees of cardiac dysfunction. We took advantage of the availability of anti- Trypanosoma cruzi microsomal fraction monoclonal antibodies (MoAbs) reactive with epitopes that are recognized (5A9B11) or not recognized (1A10C11) by CDP sera. The 5A9B11- and 1A10C11-like epitopes are expressed on cruzipain. The reactivity of 5A9B11 against cruzipain was completely inhibited by sera of severe cardiopathy patients while a partial inhibition was found with sera from chagasic patients with mild disease. CDP sera did not block cruzipain recognition by 1A10C11. The antigenic determinants recognized by CDP sera appeared to be linear and carbohydrate free. When the overall anti-cruzipain immune response was evaluated, 70% of CDP with severe disease showed cruzipain titers higher than 1/800 while none of them displayed titers lower that 1/400. This report shows for the first time that the humoral immune response against epitopes expressed on cruzipain appeared to be related with the severity of chronic Chagas disease.
doi_str_mv 10.1016/S0165-2478(01)00255-3
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71214558</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0165247801002553</els_id><sourcerecordid>71214558</sourcerecordid><originalsourceid>FETCH-LOGICAL-c444t-de75b04b6dd9529cc6873343489275767850803fc67069d27e3ddc90f0067ee63</originalsourceid><addsrcrecordid>eNqFkMFOGzEQhi3UioS0jwDyqYLDlvGuvfaeEIpaghSJA7RXy7FnwShrB3sXCZ6eDYngyGXmMN_M_PoIOWbwmwGrz2_HIoqSS3UK7AygFKKoDsiUKdkUIHj5jUw_kAk5yvkRgImKV4dkwpiQqlZySv4vhi4ms6a-64aANGHexJCR9pHaNLz6jfGBmuCoNcl5Y6l7ye0QbO9joOPIPqQYvKXzB3NvMnU-o8n4g3xvzTrjz32fkX9__9zNF8Xy5up6frksLOe8LxxKsQK-qp1rRNlYO2aqxohcNaUUspZKgIKqtbWEunGlxMo520ALUEvEupqRX7u7mxSfBsy97ny2uF6bgHHIWrKScSHUlyBToFSpqhEUO9CmmHPCVm-S70x60Qz01rx-N6-3WjUw_W5eb_dO9g-GVYfuc2uvegQudgCOPp49Jp2tx2DR-YS21y76L168AetKkj4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18088283</pqid></control><display><type>article</type><title>Humoral immune response to cruzipain and cardiac dysfunction in chronic Chagas disease</title><source>Elsevier</source><creator>Duschak, Vilma G ; Riarte, Adelina ; Segura, Elsa L ; Laucella, Susana A</creator><creatorcontrib>Duschak, Vilma G ; Riarte, Adelina ; Segura, Elsa L ; Laucella, Susana A</creatorcontrib><description>The humoral immune response to epitopes expressed on cruzipain was evaluated in 31 Chagas disease patients (CDP) with different degrees of cardiac dysfunction. We took advantage of the availability of anti- Trypanosoma cruzi microsomal fraction monoclonal antibodies (MoAbs) reactive with epitopes that are recognized (5A9B11) or not recognized (1A10C11) by CDP sera. The 5A9B11- and 1A10C11-like epitopes are expressed on cruzipain. The reactivity of 5A9B11 against cruzipain was completely inhibited by sera of severe cardiopathy patients while a partial inhibition was found with sera from chagasic patients with mild disease. CDP sera did not block cruzipain recognition by 1A10C11. The antigenic determinants recognized by CDP sera appeared to be linear and carbohydrate free. When the overall anti-cruzipain immune response was evaluated, 70% of CDP with severe disease showed cruzipain titers higher than 1/800 while none of them displayed titers lower that 1/400. This report shows for the first time that the humoral immune response against epitopes expressed on cruzipain appeared to be related with the severity of chronic Chagas disease.</description><identifier>ISSN: 0165-2478</identifier><identifier>EISSN: 1879-0542</identifier><identifier>DOI: 10.1016/S0165-2478(01)00255-3</identifier><identifier>PMID: 11578687</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Adult ; Aged ; Antibodies, Blocking - blood ; Antibodies, Protozoan - biosynthesis ; Antibodies, Protozoan - blood ; Antibodies, Protozoan - metabolism ; Antibody Specificity - immunology ; Antigens, Protozoan - chemistry ; Antigens, Protozoan - immunology ; Binding Sites, Antibody ; Binding, Competitive - immunology ; Carbohydrates - blood ; Carbohydrates - immunology ; Chagas Cardiomyopathy - blood ; Chagas Cardiomyopathy - immunology ; Chagas Cardiomyopathy - physiopathology ; Chagas disease ; Chronic Disease ; Cruzipain ; Cysteine Endopeptidases - immunology ; Enzyme-Linked Immunosorbent Assay ; Epitopes - blood ; Epitopes - chemistry ; Epitopes - immunology ; Humans ; Middle Aged ; Protozoan Proteins ; Trypanosoma cruzi</subject><ispartof>Immunology letters, 2001-10, Vol.78 (3), p.135-142</ispartof><rights>2001 Elsevier Science B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c444t-de75b04b6dd9529cc6873343489275767850803fc67069d27e3ddc90f0067ee63</citedby><cites>FETCH-LOGICAL-c444t-de75b04b6dd9529cc6873343489275767850803fc67069d27e3ddc90f0067ee63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11578687$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Duschak, Vilma G</creatorcontrib><creatorcontrib>Riarte, Adelina</creatorcontrib><creatorcontrib>Segura, Elsa L</creatorcontrib><creatorcontrib>Laucella, Susana A</creatorcontrib><title>Humoral immune response to cruzipain and cardiac dysfunction in chronic Chagas disease</title><title>Immunology letters</title><addtitle>Immunol Lett</addtitle><description>The humoral immune response to epitopes expressed on cruzipain was evaluated in 31 Chagas disease patients (CDP) with different degrees of cardiac dysfunction. We took advantage of the availability of anti- Trypanosoma cruzi microsomal fraction monoclonal antibodies (MoAbs) reactive with epitopes that are recognized (5A9B11) or not recognized (1A10C11) by CDP sera. The 5A9B11- and 1A10C11-like epitopes are expressed on cruzipain. The reactivity of 5A9B11 against cruzipain was completely inhibited by sera of severe cardiopathy patients while a partial inhibition was found with sera from chagasic patients with mild disease. CDP sera did not block cruzipain recognition by 1A10C11. The antigenic determinants recognized by CDP sera appeared to be linear and carbohydrate free. When the overall anti-cruzipain immune response was evaluated, 70% of CDP with severe disease showed cruzipain titers higher than 1/800 while none of them displayed titers lower that 1/400. This report shows for the first time that the humoral immune response against epitopes expressed on cruzipain appeared to be related with the severity of chronic Chagas disease.</description><subject>Adult</subject><subject>Aged</subject><subject>Antibodies, Blocking - blood</subject><subject>Antibodies, Protozoan - biosynthesis</subject><subject>Antibodies, Protozoan - blood</subject><subject>Antibodies, Protozoan - metabolism</subject><subject>Antibody Specificity - immunology</subject><subject>Antigens, Protozoan - chemistry</subject><subject>Antigens, Protozoan - immunology</subject><subject>Binding Sites, Antibody</subject><subject>Binding, Competitive - immunology</subject><subject>Carbohydrates - blood</subject><subject>Carbohydrates - immunology</subject><subject>Chagas Cardiomyopathy - blood</subject><subject>Chagas Cardiomyopathy - immunology</subject><subject>Chagas Cardiomyopathy - physiopathology</subject><subject>Chagas disease</subject><subject>Chronic Disease</subject><subject>Cruzipain</subject><subject>Cysteine Endopeptidases - immunology</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Epitopes - blood</subject><subject>Epitopes - chemistry</subject><subject>Epitopes - immunology</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>Protozoan Proteins</subject><subject>Trypanosoma cruzi</subject><issn>0165-2478</issn><issn>1879-0542</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNqFkMFOGzEQhi3UioS0jwDyqYLDlvGuvfaeEIpaghSJA7RXy7FnwShrB3sXCZ6eDYngyGXmMN_M_PoIOWbwmwGrz2_HIoqSS3UK7AygFKKoDsiUKdkUIHj5jUw_kAk5yvkRgImKV4dkwpiQqlZySv4vhi4ms6a-64aANGHexJCR9pHaNLz6jfGBmuCoNcl5Y6l7ye0QbO9joOPIPqQYvKXzB3NvMnU-o8n4g3xvzTrjz32fkX9__9zNF8Xy5up6frksLOe8LxxKsQK-qp1rRNlYO2aqxohcNaUUspZKgIKqtbWEunGlxMo520ALUEvEupqRX7u7mxSfBsy97ny2uF6bgHHIWrKScSHUlyBToFSpqhEUO9CmmHPCVm-S70x60Qz01rx-N6-3WjUw_W5eb_dO9g-GVYfuc2uvegQudgCOPp49Jp2tx2DR-YS21y76L168AetKkj4</recordid><startdate>20011001</startdate><enddate>20011001</enddate><creator>Duschak, Vilma G</creator><creator>Riarte, Adelina</creator><creator>Segura, Elsa L</creator><creator>Laucella, Susana A</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>M7N</scope><scope>7X8</scope></search><sort><creationdate>20011001</creationdate><title>Humoral immune response to cruzipain and cardiac dysfunction in chronic Chagas disease</title><author>Duschak, Vilma G ; Riarte, Adelina ; Segura, Elsa L ; Laucella, Susana A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c444t-de75b04b6dd9529cc6873343489275767850803fc67069d27e3ddc90f0067ee63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antibodies, Blocking - blood</topic><topic>Antibodies, Protozoan - biosynthesis</topic><topic>Antibodies, Protozoan - blood</topic><topic>Antibodies, Protozoan - metabolism</topic><topic>Antibody Specificity - immunology</topic><topic>Antigens, Protozoan - chemistry</topic><topic>Antigens, Protozoan - immunology</topic><topic>Binding Sites, Antibody</topic><topic>Binding, Competitive - immunology</topic><topic>Carbohydrates - blood</topic><topic>Carbohydrates - immunology</topic><topic>Chagas Cardiomyopathy - blood</topic><topic>Chagas Cardiomyopathy - immunology</topic><topic>Chagas Cardiomyopathy - physiopathology</topic><topic>Chagas disease</topic><topic>Chronic Disease</topic><topic>Cruzipain</topic><topic>Cysteine Endopeptidases - immunology</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Epitopes - blood</topic><topic>Epitopes - chemistry</topic><topic>Epitopes - immunology</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>Protozoan Proteins</topic><topic>Trypanosoma cruzi</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Duschak, Vilma G</creatorcontrib><creatorcontrib>Riarte, Adelina</creatorcontrib><creatorcontrib>Segura, Elsa L</creatorcontrib><creatorcontrib>Laucella, Susana A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Immunology letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Duschak, Vilma G</au><au>Riarte, Adelina</au><au>Segura, Elsa L</au><au>Laucella, Susana A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Humoral immune response to cruzipain and cardiac dysfunction in chronic Chagas disease</atitle><jtitle>Immunology letters</jtitle><addtitle>Immunol Lett</addtitle><date>2001-10-01</date><risdate>2001</risdate><volume>78</volume><issue>3</issue><spage>135</spage><epage>142</epage><pages>135-142</pages><issn>0165-2478</issn><eissn>1879-0542</eissn><abstract>The humoral immune response to epitopes expressed on cruzipain was evaluated in 31 Chagas disease patients (CDP) with different degrees of cardiac dysfunction. We took advantage of the availability of anti- Trypanosoma cruzi microsomal fraction monoclonal antibodies (MoAbs) reactive with epitopes that are recognized (5A9B11) or not recognized (1A10C11) by CDP sera. The 5A9B11- and 1A10C11-like epitopes are expressed on cruzipain. The reactivity of 5A9B11 against cruzipain was completely inhibited by sera of severe cardiopathy patients while a partial inhibition was found with sera from chagasic patients with mild disease. CDP sera did not block cruzipain recognition by 1A10C11. The antigenic determinants recognized by CDP sera appeared to be linear and carbohydrate free. When the overall anti-cruzipain immune response was evaluated, 70% of CDP with severe disease showed cruzipain titers higher than 1/800 while none of them displayed titers lower that 1/400. This report shows for the first time that the humoral immune response against epitopes expressed on cruzipain appeared to be related with the severity of chronic Chagas disease.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>11578687</pmid><doi>10.1016/S0165-2478(01)00255-3</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0165-2478
ispartof Immunology letters, 2001-10, Vol.78 (3), p.135-142
issn 0165-2478
1879-0542
language eng
recordid cdi_proquest_miscellaneous_71214558
source Elsevier
subjects Adult
Aged
Antibodies, Blocking - blood
Antibodies, Protozoan - biosynthesis
Antibodies, Protozoan - blood
Antibodies, Protozoan - metabolism
Antibody Specificity - immunology
Antigens, Protozoan - chemistry
Antigens, Protozoan - immunology
Binding Sites, Antibody
Binding, Competitive - immunology
Carbohydrates - blood
Carbohydrates - immunology
Chagas Cardiomyopathy - blood
Chagas Cardiomyopathy - immunology
Chagas Cardiomyopathy - physiopathology
Chagas disease
Chronic Disease
Cruzipain
Cysteine Endopeptidases - immunology
Enzyme-Linked Immunosorbent Assay
Epitopes - blood
Epitopes - chemistry
Epitopes - immunology
Humans
Middle Aged
Protozoan Proteins
Trypanosoma cruzi
title Humoral immune response to cruzipain and cardiac dysfunction in chronic Chagas disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T19%3A47%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Humoral%20immune%20response%20to%20cruzipain%20and%20cardiac%20dysfunction%20in%20chronic%20Chagas%20disease&rft.jtitle=Immunology%20letters&rft.au=Duschak,%20Vilma%20G&rft.date=2001-10-01&rft.volume=78&rft.issue=3&rft.spage=135&rft.epage=142&rft.pages=135-142&rft.issn=0165-2478&rft.eissn=1879-0542&rft_id=info:doi/10.1016/S0165-2478(01)00255-3&rft_dat=%3Cproquest_cross%3E71214558%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c444t-de75b04b6dd9529cc6873343489275767850803fc67069d27e3ddc90f0067ee63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=18088283&rft_id=info:pmid/11578687&rfr_iscdi=true